Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Human podocytes | Human | urinary system | unknown | adherent | miRNA | K2 Transfection System | application note | ![]() |
|||||
Mouse podocytes | Mouse | urinary system | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | F. Kliewe et al., SCIENTIfIC REPORTS, nature.com, 7: 9916, DOI:10.1038/s41598-017-10116-4 | Link | |||
Mouse immortalized differentiated podocytes | Mouse | urinary system | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | J. G. Greiten et al., The FASEB Journal, 2021, 35: e21560, DOI: 10.1096/fj.202001179RR | Link | |||
293A |
Human embryonic kidney adenovirus producer cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | miRNA | K2 Transfection System | publication | H. Qiu et al., Cell Death and Differentiation, 2016, 23: 1658-1669, doi:10.1038/cdd.2016.56 | Link | |||
293A |
Human embryonic kidney adenovirus producer cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | H. Qiu et al., Cell Death and Differentiation, 2016, 23: 1658-1669, doi:10.1038/cdd.2016.56 | Link | ||
293FT |
Human embryonic kidney virus producer cell line (derivat of 293T) | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | miRNA | RNA-Interference | K2 Transfection System | publication | V. Burghi et al., Front. Pharmacol., 2019, 10: 146, doi: 10.3389/fphar.2019.00146 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | CRISPR | K2 Transfection System | publication | D. Marks et al., bioRxiv preprint, 2021, doi.org/10.1101/2021.09.15.460502 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | B. Giotti et al., J. Mol. Cell Biol., 2019, 11(8): 703–718, doi:10.1093/jmcb/mjy063 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | E. Echeverría et al., Front. Pharmacol., 2020, 11: 113, doi: 10.3389/fphar.2020.00113 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | C. D. Zappia et al., Cells, 2021, 10, 3026, doi.org/10.3390/cells10113026 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | C. D. Zappia et al., Scientific Reports, 2015, 5:17476, DOI: 10.1038/srep17476 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/miRNA) | K2 Transfection System | publication | Z. Cai et al., Exp. & Mol. Med., 2018, 50:45, DOI 10.1038/s12276-018-0068-3 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | C. Stegmann et al., J. of Virology, 2019, 93: 11, e00138-19, doi.org/10.1128/JVI.00138-19 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | C. I. McCarthy et al., J. Gen. Physiol., 2020, 152, 5: e201912492, doi.org/10.1085/jgp.201912492 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | D. Marks et al., bioRxiv preprint, 2021, doi.org/10.1101/2021.09.15.460502 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | L. Iarriccio et al., PLOS ONE, 2015, DOI:10.1371/journal.pone.0142980 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | C. Zappia et al., Pharmacol. Res. Perspect, 2019, e00531, DOI: 10.1002/prp2.531 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | V. Burghi et al., Front. Pharmacol., 2019, 10: 146, doi: 10.3389/fphar.2019.00146 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | N. Alonso et al.; Front. Pharmacol., 6:45. doi:10.3389/fphar.2015.00045 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | A. Rodrıguez Gonzalez et al., The FEBS J., 2020, 288:229–243, doi:10.1111/febs.15344 |